Market by Type, Application, End-user, and Country Outlook | Forecast 2021-2028
As per Triton’s report, the Middle East and Africa market for botulinum toxin is anticipated to progress with a CAGR of 5.42% over the forecasting years from 2021 to 2028.
The countries scrutinized in
this market include:
• The United Arab Emirates
• South Africa
• Saudi Arabia
• Turkey
• Rest of MEA countries
In Saudi Arabia, cosmetic
surgery was previously prohibited as it did not align with religious beliefs.
The public was also wary of the health risks associated with cosmetic surgery.
However, the general attitude regarding the risks and safety of these
procedures has improved, with the emergence of innovations and new techniques,
along with the recommendations and advice from family and friends. This has
significantly boosted the adoption of botulinum toxin products in the country.
On the other hand, women in
the UAE tend to opt for surgical procedures, such as breast implants,
rhinoplasty, tummy tucks, and other non-invasive procedures such as Botox and
fillers. The aesthetics industry on the rise, driven by the rising awareness
and social media. In fact, the industry is evolving so rapidly in the country,
that Dubai is now being considered the “Beverly Hills of the Middle East.”
Cosmetic surgery has topped the list of medical procedures for medical tourism
in Dubai. The Dubai Health Authority (DHA) has stated that the emirate boasts
of the highest number of cosmetic surgeons per capita in the region. The
flourishing aesthetics industry is proving to be beneficial for the growth of
the UAE’s botulinum toxin market.
Merz Pharma is an aesthetics
and neurotoxin company of international repute. Its main focus lies on its
innovation and strategic acquisitions. The company focuses on both organic and
inorganic growth. Established on March 9, 1908, Merz Pharma has a business presence
in different regions, such as Europe, the Middle East, Latin America, North
America, and the Asia-Pacific. Merz Aesthetics is a division of the Merz Pharma
Group, which is solely dedicated to the field of aesthetics. It has developed
top treatment solutions in the areas of dermatology and skin care.
Market By Type, Application, E ..
VIEW REPORT
Market By Offerings, Technolog ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT1. MIDDLE
EAST AND AFRICA BOTULINUM TOXIN MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. KEY
INSIGHTS
2.1.1. SURGE
IN DISPOSABLE INCOME
2.1.2. GROWING
NUMBER OF MEN OPTING FOR COSMETIC TREATMENT
2.1.3. DEVELOPMENT
OF HEALTHCARE INFRASTRUCTURE
2.2. IMPACT
OF COVID-19 ON THE BOTULINUM TOXIN INDUSTRY
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE
2.3.3. BARGAINING
POWER OF SUPPLIERS
2.3.4. BARGAINING
POWER OF BUYERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS MATRIX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. NEW
PRODUCT LAUNCHES
2.7. MARKET
DRIVERS
2.7.1. INCREASING
DEMAND FOR AESTHETIC PROCEDURES
2.7.2. EXPANSION
OF BOTULINUM TOXIN INTO THERAPEUTIC APPLICATIONS
2.8. MARKET
RESTRAINTS
2.8.1. ADVERSE
EFFECTS ASSOCIATED WITH BOTULINUM TOXIN
2.8.2. LACK
OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES
2.8.3. LACK
OF INTERCHANGEABILITY BETWEEN BOTULINUM TOXIN PRODUCTS
2.9. MARKET
OPPORTUNITIES
2.9.1. INCREASING
AGING POPULATION
2.9.2. RISE
IN MEDICAL TOURISM
3. MIDDLE
EAST AND AFRICA BOTULINUM TOXIN MARKET – BY TYPE
3.1. TYPE A
3.2. TYPE B
4. MIDDLE
EAST AND AFRICA BOTULINUM TOXIN MARKET – BY APPLICATION
4.1. COSMETIC
APPLICATIONS
4.1.1. GLABELLAR
LINES
4.1.2. LATERAL
CANTHAL LINES (CROW’S FEET)
4.1.3. FOREHEAD
LINES
4.1.4. OTHER
COSMETIC APPLICATIONS
4.2. NON-COSMETIC
APPLICATIONS
4.2.1. DYSTONIA
4.2.2. CHRONIC
MIGRAINE
4.2.3. OPHTHALMOLOGIC
DISORDERS
4.2.4. OTHER
NON-COSMETIC APPLICATIONS
5. MIDDLE
EAST AND AFRICA BOTULINUM TOXIN MARKET – BY END-USER
5.1. HOSPITALS
5.2. CLINICS
AND OTHERS
6. MIDDLE
EAST AND AFRICA BOTULINUM TOXIN MARKET – REGIONAL OUTLOOK
6.1. COUNTRY
ANALYSIS
6.1.1. UNITED
ARAB EMIRATES
6.1.2. TURKEY
6.1.3. SAUDI
ARABIA
6.1.4. SOUTH
AFRICA
6.1.5. REST
OF MIDDLE EAST & AFRICA
7. COMPETITIVE
LANDSCAPE
7.1. ABBVIE
INC
7.2. EVOLUS
INC
7.3. GALDERMA
PHARMA SA (ACQUIRED BY EQT)
7.4. HUGEL
INC
7.5. IPSEN
PHARMA
7.6. MERZ
PHARMA
7.7. MEDYTOX
INC
7.8. REVANCE
THERAPEUTICS INC
7.9. US
WORLDMEDS LLC
8. METHODOLOGY
& SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: MARKET ATTRACTIVENESS
MATRIX
TABLE 3: VENDOR SCORECARD
TABLE 4: LIST OF NEW PRODUCT
LAUNCHES
TABLE 5: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 6: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 7: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $
MILLION)
TABLE 8: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $
MILLION)
TABLE 9: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 10: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
FIGURE 1: PORTER’S FIVE FORCES
ANALYSIS
FIGURE 2: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY TYPE, 2020 & 2028 (IN %)
FIGURE 3: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY TYPE A, 2021-2028 (IN $ MILLION)
FIGURE 4: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY TYPE B, 2021-2028 (IN $ MILLION)
FIGURE 5: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 6: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $
MILLION)
FIGURE 7: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY GLABELLAR LINES, 2021-2028 (IN $ MILLION)
FIGURE 8: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY LATERAL CANTHAL LINES (CROW’S FEET),
2021-2028 (IN $ MILLION)
FIGURE 9: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2021-2028 (IN $ MILLION)
FIGURE 10: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY OTHER COSMETIC APPLICATIONS, 2021-2028 (IN $
MILLION)
FIGURE 11: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $
MILLION)
FIGURE 12: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY DYSTONIA, 2021-2028 (IN $ MILLION)
FIGURE 13: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2021-2028 (IN $ MILLION)
FIGURE 14: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY OPHTHALMOLOGIC DISORDERS, 2021-2028 (IN $
MILLION)
FIGURE 15: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY OTHER NON-COSMETIC APPLICATIONS, 2021-2028
(IN $ MILLION)
FIGURE 16: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY END-USER, 2020 & 2028 (IN %)
FIGURE 17: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)
FIGURE 18: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, BY CLINICS AND OTHERS, 2021-2028 (IN $ MILLION)
FIGURE 19: MIDDLE EAST AND
AFRICA BOTULINUM TOXIN MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 20: UNITED ARAB
EMIRATES BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 21: TURKEY BOTULINUM
TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 22: SAUDI ARABIA BOTULINUM
TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: SOUTH AFRICA
BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)
FIGURE 24: REST OF MIDDLE EAST
& AFRICA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)